Contagion Live: Targeting Lung Blood Vessel Inflammation in COVID-19 Patients
UC cardiologist discusses use of razuprotafib to lessen blood vessel inflammation
Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, was interviewed by a reporter for Contagion Live about a new phase 2 clinical trial UC and UC Health are conducting using the drug razuprotafib, to lessen inflammation of the blood vessels in COVID-19 patients. Razuprotafib activates a key pathway for stabilizing blood vessels in the lungs and may prevent or treat respiratory distress in COVID-19 patients. Becker, also a UC Health cardiologist, and Duncan Hite, a professor in the UC College of Medicine, and medical director of critical care at UC Health, are overseeing the trial using razuprotafib at UC. The drug is being used as a part of clinical trial in 20 sites across the nation.
Listen to the Contagion Live interview online.
Learn more about the research involving Dr. Becker and Dr. Hite.
Related Stories
Simple ways to find a deeper sense of happiness and well being
October 8, 2026
UC assistant professor Suzie White, featured in an AARP story on practical ways to live a happier, healthier life, shared research-backed strategies for increasing well-being through gratitude and service to others. White teaches Happiness in Action, a course that helps students apply the science of happiness in everyday life.
New vending machine helps people with addiction
October 8, 2026
The University of Cincinnati's Daniel Arendt was featured in a Spectrum News report on a new harm reduction vending machine installed at the IPM Food Pantry in partnership with the Hamilton County Mental Health and Recovery Services Board.
UC study correlates increased physical activity with slower Parkinson’s progression
October 7, 2026
Higher levels of physical activity were associated with slower declines in thinking and memory as well as slower worsening of movement symptoms for people with Parkinson’s disease, according to a new study led by University of Cincinnati researchers published Oct. 7, 2026, in Neurology.